The following data is part of a premarket notification filed by Civatech Oncology Inc. with the FDA for Civaderm.
| Device ID | K191324 |
| 510k Number | K191324 |
| Device Name: | CivaDerm |
| Classification | Source, Brachytherapy, Radionuclide |
| Applicant | CivaTech Oncology Inc. 2810 Meridian Parkway, Suite 152 Durham, NC 27713 |
| Contact | Suzanne Babcock |
| Correspondent | Blix Winston TAMM Net, Inc. 2600 Mullinix Mill Road Mt. Airy, MD 21771 |
| Product Code | KXK |
| CFR Regulation Number | 892.5730 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2019-05-16 |
| Decision Date | 2019-09-20 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 00869497000128 | K191324 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CIVADERM 97310889 not registered Live/Pending |
CivaTech Oncology Inc. 2022-03-14 |
![]() CIVADERM 88098586 not registered Live/Pending |
CivaTech Oncology Inc. 2018-08-30 |
![]() CIVADERM 77925198 not registered Dead/Abandoned |
Winston Laboratories, Inc. 2010-02-01 |